P
PDS Biotechnology Corporation (PDSB)
NCM – Real Time Price. Currency in USD
0.89
-0.01 (-0.62%)
At close: Jun 26, 2026, 4:00 PM EDT
0.90
+0.01 (1.40%)
After-hours: Jun 26, 2026, 7:30 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.89
-0.01 (-0.62%)
At close: Jun 26, 2026, 4:00 PM EDT
0.90
+0.01 (1.40%)
After-hours: Jun 26, 2026, 7:30 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $21.7M significantly exceed its total debt $15.9M, ensuring strong financial flexibility
Total current assets $22.9M exceed Total current liabilities $10.1M, highlighting excellent liquidity
Debt-to-equity ratio (4.1) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-6.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.4M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.26 | 6.05 | 10 | |
| Quick ratio | 2.26 | 5.63 | 10 | |
| Debt to Equity | 4.07 | 0.30 | 2.0 | |
| Debt to Assets | 0.64 | 1.04 | 3.0 | |
| Interest coverage | -6.43 | -16.91 | 1.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -49K | -57K | -60K | -61K | -61K |
| Operating Income | -42M | -43M | -36M | -32M | -29M |
| Net Income | -41M | -43M | -38M | -34M | -33M |
| EBITDA | -42M | -43M | -36M | -31M | -29M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 39.68 | 5.5 |
| Next quarter | N/A | 38.6 | 5.5 |
| Current year | N/A | 32.88 | 5.5 |
| Next year | N/A | 6.04 | 3.0 |
| Weighted average score | 4.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 2.83 | 0 | -18.06 | 4.0 |
| Y/Y | 999 | 13.43 | 38.1 | 51.6 | 9.5 |
| 3y average | 999 | 5.2 | 18.95 | -4.72 | 6.3 |
| 5y average | 999 | -27.95 | -6.78 | -23 | 3.3 |
| Weighted average score | 5.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |